Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02221219Phase 2Completed
Phase 2, randomised, double-blind trial of indomethacin in Intraventricular hemorrhage (IVH) and periventricular leukomalacia (PVL) (4 arms). Primary endpoint: Percent of Survivors With no Severe IVH (Grades 3 or 4) or PVL at 60 days. Started Aug 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02221219.